Methods for isolating a target analyte from a heterogeneous sample
View Patent ↗The invention generally relates to methods of using compositions that include sets of magnetic particles, members of each set being conjugated to an antibody specific for a pathogen, and magnets to isolate a pathogen from a body fluid sample.
1. A method for isolating pathogen from a heterogeneous sample, the method comprising:
providing a vessel that contains a heterogeneous sample comprising pathogen, the vessel being coupled to a microfluidic device that comprises a channel and a magnet;
introducing to the sample a cocktail comprising a plurality of sets of magnetic particles, members of different sets being conjugated to different antibodies that are specific for different pathogen, wherein at least two of the sets are provided at different concentrations, thereby forming a mixture;
flowing the mixture from the vessel through a channel in the microfluidic device and toward a magnet in the microfluidic device; and
separating particle bound pathogen from other components in the sample by using the magnet to retain pathogen bound to magnetic particles while unbound sample components are not retained by the magnet.
2. The method of claim 1 , further comprising characterizing the pathogen.
3. The method of claim 2 , wherein characterizing comprises identifying the pathogen.
4. The method of claim 3 , wherein identifying is selected from sequencing nucleic acid derived from the pathogen or amplifying the nucleic acid.
5. The method of claim 1 , wherein the sample is a blood sample.
6. The method of claim 1 , wherein each set is present at a concentration designed for detection of a specific pathogen in said sample.
7. The method of claim 1 , wherein the particles are differently labeled.
8. The method of claim 7 , wherein the label is an optical label.
9. The method of claim 8 , wherein the optical label is a fluorescent label.
10. The method of claim 1 , wherein the antibodies are monoclonal antibodies.
11. The method of claim 1 , wherein the antibodies are polyclonal antibodies.
12. The method of claim 1 , wherein the pathogen are gram positive bacteria.
13. The method of claim 1 , wherein the pathogen are gram negative bacteria.
14. The method of claim 1 , wherein the pathogen are gram positive and gram negative bacteria.